Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment

Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment

Abstract Background Patients with refractory or relapsed acute myeloid leukemia (AML) have poor survival, necessitating the exploration of optimized therapeutic strategy. Here, we aimed to investigate clinical outcomes and health‐related quality of life (HR‐QoL) after total therapy, which included a...

Full description

Bibliographic Details
Main Authors: Chen‐hua Yan, Yu Wang, Yu‐qian Sun, Yi‐fei Cheng, Xiao‐dong Mo, Feng‐rong Wang, Yu‐hong Chen, Yuan‐yuan Zhang, Ting‐ting Han, Huan Chen, Lan‐ping Xu, Xiao‐hui Zhang, Kai‐yan Liu, Xiao‐jun Huang
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Cancer Communications
Subjects:
acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
refractory
relapsed
total therapy
Online Access:https://doi.org/10.1002/cac2.12376

Internet

https://doi.org/10.1002/cac2.12376

Similar Items